Samarpita et al. showed that cyanidin can be used as a small-molecule drug to treat patients with rheumatoid arthritis because it suppressed IL-17A, a cytokine found in the serum and synovial fluid of patients with rheumatoid arthritis [57]. The gene discussed is IL17A; the disease is rheumatoid arthritis.